- Home
- ARCT vs ECX Comparison
ARCT vs ECX Comparison
Compare ARCT & ECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARCT | ECX |
|---|---|---|
| Founded | 2013 | 2017 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.1M | 643.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ARCT | ECX |
|---|---|---|
| Price | $6.44 | $1.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 1 |
| Target Price | ★ $38.67 | $3.20 |
| AVG Volume (30 Days) | 829.5K | ★ 2.8M |
| Earning Date | 11-10-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $97,601,000.00 | ★ $822,663,229.00 |
| Revenue This Year | N/A | $772.81 |
| Revenue Next Year | N/A | $30.47 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 6.99 |
| 52 Week Low | $5.85 | $0.76 |
| 52 Week High | $24.17 | $3.25 |
Technical Indicators
Market Signals| Indicator | ARCT | ECX |
|---|---|---|
| Relative Strength Index (RSI) | 35.49 | 46.53 |
| Support Level | $6.38 | $1.60 |
| Resistance Level | $7.76 | $2.16 |
| Average True Range (ATR) | 0.43 | 0.13 |
| MACD | 0.20 | 0.01 |
| Stochastic Oscillator | 24.87 | 37.20 |
Price Performance
Historical ComparisonAbout ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
About ECX ECARX Holdings Inc. Ordinary shares
ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services in the People's Republic of China. The company's core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.